Search research articles
Contact Us
Filters
Showing results (221-230 of 250) with videos related to
Page
of 25
Sort By:
The American Journal of Cardiology
|
May 10, 2015
Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry)
Marco G Mennuni, Jonathan L Halperin, Sameer Bansilal, et al.
JACC. Cardiovascular Interventions
|
August 7, 2017
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study
Usman Baber, Jaya Chandrasekhar, Samantha Sartori, et al.
The Canadian Journal of Cardiology
|
February 25, 2018
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Journal of the American College of Cardiology
|
December 20, 2016
Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment: The YELLOW II Study
Annapoorna S Kini, Yuliya Vengrenyuk, Khader Shameer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 30, 2021
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis
Anne H Tavenier, Roxana Mehran, Mauro Chiarito, et al.
Circulation. Cardiovascular Interventions
|
June 6, 2018
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)
Usman Baber, Shawn X Li, Rebecca Pinnelas, et al.
Journal of the American College of Cardiology
|
March 29, 2020
2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques
Myong Hwa Yamamoto, Akiko Maehara, Gregg W Stone, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 10, 2020
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
JACC. Cardiovascular Interventions
|
March 24, 2017
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry
Michela Faggioni, Usman Baber, Samantha Sartori, et al.
The New England Journal of Medicine
|
November 17, 2019
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement
Ole De Backer, George D Dangas, Hasan Jilaihawi, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 250) with videos related to
Sort By:
Page
of 25
The American Journal of Cardiology
|
May 10, 2015
Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry)
Marco G Mennuni, Jonathan L Halperin, Sameer Bansilal, et al.
JACC. Cardiovascular Interventions
|
August 7, 2017
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study
Usman Baber, Jaya Chandrasekhar, Samantha Sartori, et al.
The Canadian Journal of Cardiology
|
February 25, 2018
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
Journal of the American College of Cardiology
|
December 20, 2016
Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment: The YELLOW II Study
Annapoorna S Kini, Yuliya Vengrenyuk, Khader Shameer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 30, 2021
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis
Anne H Tavenier, Roxana Mehran, Mauro Chiarito, et al.
Circulation. Cardiovascular Interventions
|
June 6, 2018
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)
Usman Baber, Shawn X Li, Rebecca Pinnelas, et al.
Journal of the American College of Cardiology
|
March 29, 2020
2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques
Myong Hwa Yamamoto, Akiko Maehara, Gregg W Stone, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 10, 2020
Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study
Jaya Chandrasekhar, Usman Baber, Samantha Sartori, et al.
JACC. Cardiovascular Interventions
|
March 24, 2017
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry
Michela Faggioni, Usman Baber, Samantha Sartori, et al.
The New England Journal of Medicine
|
November 17, 2019
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement
Ole De Backer, George D Dangas, Hasan Jilaihawi, et al.
Page
of 25